Open AccessNeuromyelitis optica spectrum disorder post-COVID-19 infection: A rare case report from Northeast India
Author(s) -
Dipankar Das,
Harsha Bhattacharjee,
Obaidur Rehman,
Nilutparna Deori,
Damaris Magdalene,
Gayatri Bharali,
Sakshi Mishra,
Kanika Godani
Publication year - 2022
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_61_22
Subject(s) - medicine , neuromyelitis optica , spectrum disorder , optic neuropathy , covid-19 , multiple sclerosis , myelitis , rituximab , spinal cord , pediatrics , disease , dermatology , pathology , immunology , optic nerve , infectious disease (medical specialty) , ophthalmology , antibody , psychiatry
Multiple sclerosis and neuromyelitis optica spectrum disorder may be seen in the acute setting of coronavirus disease 2019 (COVID-19) infection or even post-recovery. Such patients may present with optic neuropathy along with weakness in the back and lower limbs. Ascending paralysis can present with respiratory distress in acute COVID-19 infection and may even prove to be fatal. We report a unique case of a 16-year-old female with past history of COVID-19 infection having optic neuropathy, and radioimaging showing demyelinating plaques in the central nervous system with spinal cord edema. Serology showed positivity for rheumatoid arthritis, and the patient was managed with steroids and rituximab.